
Clinical
Latest News
Advertisement
Latest Videos

CME Content
Advertisement
More News



Twenty-five percent of patients receiving neoadjuvant chemotherapy treatment for ovarian cancer develop venous thromboembolism, according to a new study published in the journal Obstetrics & Gynecology.






















Advertisement
Advertisement
Trending on AJMC
1
Cytokines Linked With Drug Resistance in Ovarian Cancer, but Underlying Mechanisms Remain Unclear
2
Mepolizumab Reduces Health Care Resource Utilization, Work Impairment in Severe Asthma
3
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
4
CHEST 2025 Highlights: Future of Respiratory Vaccines and the Impact of Federal Funding Cuts
5























































